Clinical Study
Safety and Efficacy of the Prostar XL Vascular Closing Device for Percutaneous Closure of Large Arterial Access Sites
Table 3
Technical success (given in %) and number of complications at all 78 access sites based on sheath size. Additionally, values of Mann-Whitney Rank Sum Tests comparing smaller (≤16) and larger (≥18) access sites are given.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compr.: need for prolonged compression; PA (cons.): pseudoaneurysm with conservative management; PA (surg.): pseudoaneurysm with surgical management; major/minor compl.: major/minor complications. |